Fortive Corp. Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 28, 2025. Fortive Corporation operates three strategic segments: Intelligent Operating Solutions (IOS), Precision Technologies (PT), and Advanced Healthcare Solutions (AHS). The company is currently executing a plan to separate its PT segment into an independent publicly-traded company named Ralliant Corporation, targeting completion by the end of Q2 2025.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Total Sales | $1,474.2 million | $1,524.5 million |
| Gross Profit | $880.9 million | $904.2 million |
| Operating Profit | $233.6 million | $302.2 million |
| Net Earnings | $171.9 million | $207.4 million |
| Diluted EPS | $0.50 | $0.58 |
| Operating Cash Flow | $241.7 million | $256.7 million |
| Cash and Equivalents | $892.1 million | $704.6 million |
| Total Debt (Carrying Value) | $3,862.9 million | $3,707.3 million |
Margins: Gross profit margin was 59.8% (up 50 bps). Operating profit margin was 15.8% (down 400 bps). Effective tax rate was 14.6% (up from 11.4% in Q1 2024).
Material Changes vs. Prior Period
- Revenue Decline: Total sales decreased 3.3% year-over-year. Core revenue (excluding acquisitions and currency) declined 1.7%, driven by a 3.6% volume decline offset by 1.9% favorable pricing. Unfavorable foreign currency exchange rates contributed a 1.2% decrease.
- Profitability Impact: Operating profit decreased significantly due to the absence of a $63.1 million gain on the sale of property recorded in Q1 2024. This one-time gain accounted for a 415 basis point unfavorable variance in operating margin.
- Segment Performance:
- IOS: Sales increased 0.9% (Core +2.0%). Operating profit margin improved to 25.9%.
- PT: Sales decreased 10.5% (Core -8.4%). Operating profit margin dropped to 17.4% largely due to the prior year property sale gain and volume reductions.
- AHS: Sales increased 0.8% (Core +2.5%). Operating profit margin decreased slightly to 8.7%.
- Capital Allocation: The company repurchased 2.5 million shares for approximately $203 million in Q1 2025. No repurchases were made in Q1 2024.
Outlook, Risks, and Management Commentary
- Separation of PT Segment: Fortive is proceeding with the spin-off of the Precision Technologies segment into Ralliant Corporation. The Form 10 registration statement is expected to be filed in early May 2025. All PT assets and liabilities remain consolidated in these results.
- Trade and Tariff Risks: Management highlighted significant uncertainty regarding new U.S. tariffs imposed in April 2025 and retaliatory measures from China. These factors may cause supply chain disruptions, increased costs, and potential impairment of intangible assets.
- Foreign Exchange: Volatility in foreign exchange rates is expected to continue impacting financial results throughout 2025.
- Restructuring: The company incurred $3.9 million in restructuring charges in Q1 2025 related to the pending separation. Total accrued restructuring costs were $9 million as of March 28, 2025.
- Capital Expenditures: Full-year 2025 capital spending is expected to be between $120 million and $140 million.
Investor Verification Checklist
- Separation Timeline: Verify the status of the Ralliant Corporation Form 10 filing and the expected Q2 2025 completion date for the spin-off.
- Tariff Impact Quantification: Monitor future disclosures for specific financial modeling regarding the impact of new U.S. tariffs and Chinese retaliatory measures on margins and supply chains.
- PT Segment Volume Trends: Assess whether the 8.4% core revenue decline in the PT segment is a temporary cyclical dip or a structural shift, given the upcoming separation.
- Debt Maturities: Review the debt schedule, noting the Euro Term Loan and Yen Term Loan due in 2025, and the company's refinancing strategy.
- Core Revenue Drivers: Analyze the divergence between favorable pricing (+1.9%) and volume declines (-3.6%) to understand demand elasticity in key end markets.